elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42285709-7B543D5C-1BF1-4604-B74C-0FBC17175C16
Q42285709-7B543D5C-1BF1-4604-B74C-0FBC17175C16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42285709-7B543D5C-1BF1-4604-B74C-0FBC17175C16
The reversible P2Y12 antagonist ACT-246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat.
P2860
Q42285709-7B543D5C-1BF1-4604-B74C-0FBC17175C16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42285709-7B543D5C-1BF1-4604-B74C-0FBC17175C16
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfcc58cd441c4c88835d3bba5f129c1875dafd78
P2860
The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature.